All posts by imreal

Sikka Software collaborates with Sphere to Launch Sikka Payments


With this powerful payment solution, dental practices can accept patient payments from a variety of channels, all seamlessly integrated into their practice management system, eliminating the need for manual reconciliation

Sikka Software, a market leader in advancing retail healthcare connectivity, and Sphere, the leading provider of end-to-end integrated payments and security software, today announced the launch of a new payment platform, Sikka Payments, for dentists and their patients. This innovative platform is designed to equip patients with a pay-anywhere capability and automate the payment and reconciliation process for providers. The announcement came during the Greater New York Dental Meeting, a global event featuring some of the best new products and services for dental professionals.

Sikka Payments makes it easier than ever to harness the increased capabilities, enhanced security, and reduced costs associated with processing electronic payments. Mobile payments allow providers to request and accept payments remotely, preserving the doctor patient relationship and creating additional opportunities for the practice to accelerate accounts receivable collections. With this powerful payment solution, dental practices can accept patient payments from a variety of channels, all seamlessly integrated into their practice management system, eliminating the need for manual reconciliation. These features make it easier for providers to collect payments earlier, provide a better patient payment experience and maximize cash flow in the practice. Sikka Payments is built on the HIPAA and HITECH compliant Sikka Platform Cloud which connects to the majority of retail healthcare applications, including 96% of dental practice management systems.

Sphere brings healthcare payments full circle, delivering easy to integrate payment processing technology and cost-effective processing that is highly secure and compliant. Sikka Payments users will now be able to offer patients more options for when and how their patients pay without any disruption to the office workflow.

In conjunction with this solution launch, and Sikka’s expansion into Fintech, the company has also announced the appointment of Rory Byrne, as General Manager of Fintech. Rory has over 20 years’ experience in enterprise software sales, payments strategy, and business development. Prior to joining Sikka, Rory was EVP of Business Development at Billtrust, where he was responsible for B2B payments strategy, strategic partnerships, and M&A. Rory brings expertise from a variety of executive and leadership roles in sales, marketing, and business development including Visa, Yahoo!, Hyperion, and Kofax. This role will help Sikka address the growing demand for Fintech services in the retail healthcare market.

“Dental offices need three key things from a payment application; to save time by making it easier for the team to accept payments, to save money by providing the best rates, and to provide today’s hyper connected patients with an easy and convenient way to pay from anywhere,” said Vijay Sikka, Founder and CEO of Sikka Software. “Sikka Payments, launched in collaboration with Sphere, delivers on each of these three things, and revolutionizes payments in the dental industry”.

“Sikka has built a proven platform that allows practices to leverage innovative third-party applications to improve operational efficiencies,” said Steve Rizzuto, Chief Executive Officer of Sphere. “With the addition of Sikka Payments, dentists now have a single source to maximize their practices in an integrated, secure, and frictionless way.”

Dentists interested in Sikka Payments can find out more at http://www.sikkapayments.com.

About Sphere

Sphere, powered by TrustCommerce, is a software and financial technology company providing integrated solutions that reduce friction and facilitate better and more secure commercial interactions with customers in specialized verticals markets, primarily healthcare, non-profit, transportation and education. Sphere’s integrated payments technology and security software enable its clients to process payments in a way that is: highly secure and compliant, integrated with their core business software, omnichannel, and processor-neutral. Sphere’s partner-centric focused payments solutions serve small, midsize and enterprise level businesses and software companies in the U.S., Canada, and Australia.

About Sikka Software     

Sikka Software is helping to rethink the retail healthcare market using a single API cloud platform with Artificial Intelligence and Predictive Analytics. Focusing on non-physician practices in dentistry, audiology, veterinary, optometry, chiropractic, orthodontic and oral surgery etc., Sikka Software now has over 34,000 practice installations on its platform. These are businesses where the primary skilled workers are also the owners who need tools to digitize their practices and help them make more real-time, optimized decisions. Sikka Software API and cloud platform connect to 90% of the retail healthcare market including practice management systems and financial software.

Share article on social media or email:

Real Time Pain Relief Partners with Olympian and America’s Coach Jeff Galloway to Launch New Sweat-Resistant Formula for Working Out


Galloway is featured on a co-branded 3 oz Roll-On Real Time ACTIVE Pain Relief Cream.

“I’ve recommended it to hundreds of runners and I have only received positive feedback,” said Jeff Galloway.

Real Time Pain Relief, makers of the popular rub-on pain relief lotion and products, today announced they have partnered with Jeff Galloway. A lifetime runner, All-American collegiate athlete and member of the 1972 US Olympic Team in the 10,000 meters, Galloway has spent his life teaching others how to get active and stay active. From the young cross-country hopeful to the middle age newbie, his lectures and books have helped over a million people cross the finish line and earned him the title of America’s Coach.

Galloway designed his method in 1973 to help beginners start running. Strategic walk breaks allow the runner to control fatigue, virtually eliminating significant running injuries. He does not adhere to the “no pain, no gain” mantra. Instead, Galloway is often heard saying, “Fitness, when done correctly always leaves you feeling better.” For this reason, Real Time Pain Relief is proud to partner with Galloway, to support anyone’s fitness goals with Real Time ACTIVE Pain Relief Cream.

Galloway is featured on a co-branded 3 oz Roll-On Real Time ACTIVE Pain Relief Cream that will be promoted in his newsletters, social media and his running stores. It is available for purchase here. The new formula is homeopathic and provides gentle but effective pain relief. Users can stay focused on their workout while enjoying the following benefits:

  • Sweat-resistant and absorbs quickly without any greasy residue.
  • No harsh chemicals – free of parabens, SLS, artificial dyes, GMOs, NSAIDs and acetaminophen.
  • No burn. Contains less menthol than many other leading brands – no burn or uncomfortable topical sensation.
  • No medicinal smell.


“I’ve been using Real Time Pain Relief and like it a lot,” said Galloway. “I’ve recommended it to hundreds of runners and I have only received positive feedback. I’m happy to be a part of the Real Time Pain Relief team.”

“Jeff’s approach helps anyone create a doable plan that opens up to the possibility of a life-changing experience of finishing a distance event,” said Meredith Wolfley, Director of Partnerships at Real Time Pain Relief. “His methods reduce aches, pains and injuries while helping people of all abilities enjoy exercise at any age. We’re thrilled to have Jeff partner with RTPR to promote Real Time ACTIVE Pain Relief Cream.”

Visit https://rtpr.com/active-pain-relief to purchase Real Time Pain Relief products or go to http://www.jeffgalloway.com/ to learn more about Jeff Galloway.

About Real Time Pain Relief (RTPR)

For over 20 years, Real Time Pain Relief has made pain relief lotions available to families across America. In 2019, RTPR partnered with legendary champion George Foreman to launch its most powerful pain relief solution ever – George Foreman’s Knockout FormulaTM. Infused with nature’s ingredients and free of NSAIDs, acetaminophen, parabens, SLS, and artificial dyes, Real Time Pain Relief formulas contain the recipe for success. For pain relief you can trust, choose Real Time Pain Relief. Real Time Pain Relief is an FDA registered OTC, pain relief product. Visit rtpr.com to learn more about Real Time Pain Relief.

Share article on social media or email:

TrialScope Launches Clinical Trials Website for EMD Serono


EMD Serono Clinical Trials website

EMD Serono Clinical Trials website

“Both EMD Serono and TrialScope share a commitment to clinical trial transparency, awareness and patient engagement.” – TrialScope CEO Jeff Kozloff

TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website, https://clinicaltrials.emdgroup.com. This site is designed to educate and inform patients, caregivers, the public, patient advocacy groups and healthcare professionals (HCPs) about the clinical trial journey, as well as provide specific information about clinical trials conducted by Merck KGaA, Darmstadt, Germany, and its affiliates.

In an effort to keep clinical trial participants fully informed, the website provides an overview of the different phases of research, as well as outlines each step the patient will encounter through the clinical trial process. The site also provides access to trial results and other available post-trial information, such as plain language summaries and clinical study report synopses. This is made possible through the TrialScope Engage™ platform that automatically syncs approved clinical trial data from TrialScope Disclose™, the global disclosure system used by Merck KGaA, Darmstadt, Germany. The site also provides impactful information about clinical research to healthcare professionals, which helps them raise awareness about the importance of clinical trials and discuss potential participation in clinical trials with their patients. An extensive FAQ section, with more than 30 questions and answers, provides a comprehensive overview of clinical trials.

“Both EMD Serono and TrialScope share a commitment to clinical trial transparency, awareness and patient engagement,” said TrialScope CEO Jeff Kozloff. “Together, we sought input from multiple patient stakeholders to develop an informative and well-designed site that will help accelerate patient knowledge, understanding and connections to relevant clinical trial information.”

To ensure that the website content meets the needs of patients, TrialScope and EMD Serono worked with the Center for Information and Study on Clinical Research Participation (CISCRP) to gather feedback from patients and the public. According to CISCRP, 75 percent of the general public is willing to participate in a clinical trial, yet only 30 percent have a basic understanding of what clinical research is. Insights gleaned from people who had previously searched for trials guided not only the content but the manner in which it is presented.

About TrialScope

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 16 of the top 20 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit TrialScope.com.

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. In the U.S. and Canada, Merck KGaA, Darmstadt,

Germany operates its healthcare business as EMD Serono. Around 56,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 countries.

About CISCRP

The Center for Information and Study on Clinical Research Participation is a first-of-its-kind nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media and policy makers about clinical research and the role each party plays in the process.

Share article on social media or email:

How To Select A Safer And Cheaper To Insure Car


News Image

“It is important for drivers to pick a safe car for driving. Not only a safe car will protect the lives of its occupants, but it will also help lower the insurance premiums”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Carinsuranceplan.org has launched a new blog post that explains how drivers can pick a safe car to drive and save car insurance money at the same time.

For more info and free car insurance quotes, visit https://carinsuranceplan.org/pick-safe-car/

When shopping for a new vehicle, one of the main concerns a policyholder can have is how safe is the car is going to purchase? Choosing a safe car is important for drivers that want to keep their loved ones as safe as possible while they are on the road. Besides that, safe cars can help drivers pay less on their insurance policies.

The following tips can help drivers pick a safe car:


  • Check the crash test scores. Vehicles with good scores will better protect their occupants from injuries or even death. Policyholders should look for “Good” front moderate overlap, small overlap, side-impact, and roof scores from the IIHS. IIHS tests evaluate two aspects of safety: crashworthiness – how well a vehicle protects its occupants in case of a crash, and crash avoidance and mitigation features – technology that can prevent a collision or lessen its severity.
  • Look for vehicles with side airbags. While frontal crashes are the most frequent type of collisions, side impacts are the second most common but are by far more likely to be fatal. Policyholders should buy cars that come with side head airbags besides every occupant seat and at a minimum, torso airbags besides the front passengers.
  • Analyze the car size and weight. Larger and heavier vehicles are safer than smaller ones. However, some big cars are prone to rollovers or other issues. Mid-sized sedans with high safety ratings are considered ideal choices.
  • Crash avoidance technologies. According to the National Highway Traffic Safety Administration (NHTSA), 94 percent of fatal crashes is because a human being made an error or a poor choice. Crash avoidance technologies can sense what’s going around a vehicle and will either act in the place of the drivers or alert them. Ever improving technologies like advanced braking and warning systems can minimize injuries and damage from collisions.


For additional info, money-saving tips and free car insurance quotes, visit https://carinsuranceplan.org/

Carinsuranceplan.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

Share article on social media or email:

Davalyn Corp Celebrating 30 Years of Recruiting


We have navigated three decades of change in an increasingly complex world through enhancing and expanding our disciplines, presence, and scope of services—and are looking forward to what’s to come over the next 30 years.

Davalyn Corporation, an industry-leading executive search firm, is proud to celebrate 30 years of recruiting top talent in the machine tools and metal manufacturing, automotive, pharmaceutical and consumer goods industries.

Founded in 1989 by Chief Executive Officer Rick Sinay, Davalyn started recruiting in milling and turning and has since expanded into more specialized technical aspects of the industries, including tungsten carbide, robotics and lasers, medical devices and scientific apparatus, as well adding new verticals in pharmaceuticals, food, consumer electronics and consumer durables. These diverse industries have all grown to become integral components of what Davalyn is today. The Davalyn team specializes in providing global clients with proven talent acquisition and retention strategies, from sales manager to C-level executives and board members, working primarily with tier one and tier two suppliers.

“Our philosophy has been and always will be high achievement through an uncompromising work ethic. We work hard for our clients, our candidates and for ourselves. Their success is our success,” says Sinay. “I am reminded every day of the friendships good service can bring. Our team has given so much time and energy to ensure our company, and our clients, grow to their full potential.”

Sinay credits Davalyn’s continued success to the experienced and dedicated team and a comprehensive approach to the search process that builds upon a thorough understanding of clients’ unique needs and qualities that allow them to present dynamic, industry-leading candidates with the personal and professional attributes needed to fulfill organizational goals.

“We are proud of our past achievements and have the technology to match any global search firm. Our high completion rate and strong level of repeat business from our major clients are our best references,” says Sinay. “We have navigated three decades of change in an increasingly complex world through enhancing and expanding our disciplines, presence, and scope of services—and are looking forward to what’s to come over the next 30 years.”

For more information about Davalyn Corporation, please visit http://www.davalyncorp.com.

Share article on social media or email:

Root Sciences Announces Partnership with Devex


Root Sciences and DEVEX have partnered to introduce cryo-ethanol as a sustainable solution for pre-distillation of crude cannabis oil.

Combining DEVEX’s 25 years of know-how and experience in the field of botanical extraction with Root Sciences’ reputation as the market leaders in the field of cannabis processing, the new partnership was formed to produce what both companies identify as “The Ultimate Cannabis Pre-Distillation Process.”

“DEVEX, as the leading German manufacturer for botanical extraction and all corresponding downstream processes (such as Evaporation-, High Concentration-, Sterilization (UHT), Vacuum- and Freeze drying technologies), is proud to present the ultimate DEVEX CryoEXS (Cryo-Ethanol-Extraction-System) which we developed together with our partner company Root Sciences.” said Claudius Oeggerli, Partner, DEVEX.

The Cryo Ethanol Extraction System Provides the Following Processes in an All-In-One System:

1. Solvent Cooling

2. Ethanol Extraction

3. Ethanol Recovery

4. Ethanol Stripping (from cannabis biomass following Ethanol Extraction)

5. Decarboxylation

“Root Sciences is pleased to partner with DEVEX to introduce the CryoEXS extraction system. DEVEX’s decades of experience, combined with our in-depth knowledge of cannabis processing, led to the development of this all-in-one extraction system, assuring high-efficiency and reliability that meets or exceeds both EU-CE-ATEX and US-UL standards, and also considers full GMP documentation as mandatory.” Added Nenad Yashruti, Founder and Sr VP Business Development, Root Sciences

You can see the CryoEXS in person at MJIZCON in Las Vegas, December 11-13, 2019 by visiting Root Sciences and DEVEX at booth C3012.

About Root Sciences

Root Sciences is the global leader in the distribution of equipment and support services for processing facilities in the cannabis and hemp industries, representing premium extraction, distillation and other post-processing technologies. Founded in 2016, Root Sciences has clients in Europe, Asia, the Middle East and North and South America. For more information, visit http://www.rootsciences.com.

Share article on social media or email:

Saba Certified as Smartchoice® Preferred Provider by Brandon Hall Group


Saba Certified Platinum Smartchoice® Preferred Provider by Brandon Hall Group

Saba Certified Platinum Smartchoice® Preferred Provider by Brandon Hall Group

Our mission is to help every company become a place where people love to work, and that means helping HR leaders create personalized, motivating and engaging talent experiences for their people

After an extensive review Brandon Hall Group confirms that Saba is living its mission to help every company become a please where people love to work.

“Saba is taking a unique, personalized approach to the talent experience, without losing sight of business goals and outcomes. Their solutions are designed to help organizations solve for the most critical talent imperatives of the future, while delivering on user demands for a simple, intuitive, and personalized journey at work,” said Michael Rochelle, Chief Strategy Officer and Principal Human Capital Management Analyst at Brandon Hall Group. “The analyst team at Brandon Hall Group supports Saba’s direction for talent management innovation and has designated Saba a Brandon Hall Group Smartchoice® Provider.”

The analyst team at Brandon Hall Group has spent years better understanding Saba as well as the market they operate. The team has conducted in depth briefings with the product teams, reviewed case studies and collected customer feedback to certify they deliver upon their message.

The program provides a world-class membership center for knowledge, resources and advisory support to the entire organization. During this time Brandon Hall Group conducted a full review of Saba product/service messaging and website, collateral marketing material and social media strategy.

“Our mission is to help every company become a place where people love to work, and that means helping HR leaders create personalized, motivating and engaging talent experiences for their people, while staying aligned to the strategic outcomes their organizations need to achieve,” said Saba CMO Theresa Damato. “We’re thrilled to be recognized by Brandon Hall as a Smartchoice® provider – it’s a validation of our market leadership, our vision for the future of work, and our commitment to deliver solutions that help our customers prove the impact their people have on business success.

Brandon Hall Group has consistently been the leading independent analyst firm and confirms that Saba offerings measurably benefit the organizations they work with.

To learn more about Smartchoice® preferred vendors or to become one, please visit http://go.brandonhall.com/l/8262/2019-11-13/9pst4l.

—About Brandon Hall Group Inc.

Brandon Hall Group is an HCM research and advisory services firm that provides insights around key performance areas, including Learning and Development, Talent Management, Leadership Development, Talent Acquisition and HR/Workforce Management.

With more than 10,000 clients globally and 25 years of delivering world-class research and advisory services, Brandon Hall Group is focused on developing research that drives performance in emerging and large organizations, and provides strategic insights for executives and practitioners responsible for growth and business results.

At the core of our offerings is a Membership Program that combines research, benchmarking and unlimited access to data and analysts. The Membership Program offers insights and best practices to enable executives and practitioners to make the right decisions about people, processes, and systems, coalesced with analyst advisory services which aim to put the research into action in a way that is practical and efficient. (http://www.brandonhall.com)

–About Saba

At Saba, we know that every organization has the potential to be a great place to work, and no matter what your business does, or who you serve, or what you sell, success starts with your people. But in today’s diverse, mobile, social world, successful organizations must deliver an experience at work that’s more connected, and more personal than ever before. And the most successful do this with Saba. Because we combine the science of talent with intelligent technology to deliver a “just-for-me” talent experience for every individual – in the moments that matter most. With powerful tools and insights talent leaders need to prove the experience makes an impact on business success. So from attracting candidates who are the perfect fit, to designing paths for personal growth, to creating a culture that nurtures the unique talents of every individual, Saba helps you give your people and teams the message: Work to your strengths. Work like you envision. Work like it’s personal. Work like you. Learn more at http://www.saba.com

Share article on social media or email:

CAP-XX acquires Murata’s supercapacitor production lines, will produce Murata’s three supercapacitor families and serve its customers from Sydney


CAP-XX to maintain Murata’s existing pricing on the small, thin DMF, DMT and DMH supercapacitor product families.

We look forward to serving Murata’s customers and are committed to providing the same high quality, low cost products that they enjoy today,” said Anthony Kongats, CAP-XX CEO.

CAP-XX (LSE:CPX), a leader in supercapacitors that deliver peak power to support or replace batteries, today announced it will acquire CAP-XX licensee Murata’s supercapacitor production lines, relocate them from Japan to a new factory in Sydney to arrive in stages between March and June 2020, and begin producing Murata’s three supercapacitor product families in Q3 2020. Murata will also assist in introducing CAP-XX to its customers.

Murata licensed CAP-XX’s patents in 2008, began production of supercapacitors in Japan in 2013, and has since significantly built its supercapacitor business. After a strategic review of its business in 2018, Murata informed CAP-XX that it wanted to focus on its multilayer ceramic capacitors and lithium batteries, and exit some of its non-core business lines including supercapacitors. Consequently, the two companies reached agreement for CAP-XX to acquire Murata’s high-quality production lines. The companies have been working together for over 12 months to ensure the successful relocation of these production lines, and for CAP-XX to be able to produce supercapacitors that are identical to what Murata makes today, guaranteeing customers a continuity of supply.

CAP-XX considers this a compelling opportunity to acquire modern, state-of-the-art production equipment from manufacturing expert Murata, whose production lines are newer, more efficient and have far greater capacity than CAP-XX’s own. The company expects the acquisition to both increase its sales and reduce its direct production costs.

Murata is building enough inventory to satisfy the needs of customers during the interim after ceasing production in Q1 2020 until CAP-XX recommences shipments using the production lines in Q3 2020.

CAP-XX plans to maintain Murata’s existing pricing on Murata’s small, thin DMF, DMT and DMH supercapacitor product families:

  •     DMT is a high-power, ultra-long life, high temperature supercapacitor suited for extreme applications such as solid-state drives and automotive applications. Due to its thinness, it can be assembled onto printed circuit boards (PCBs).
  •     DMF is a general purpose, very high power, long life supercapacitor that has very low ESR and a wider operating voltage range. It is suitable for high brightness LED flash, high-power audio, smart meters and more. It, too, can be assembled onto PCBs.
  •     DMH is an ultra-thin 0.4mm supercapacitor suited for smart phones, smart credit cards, wearables, 3V coin cell battery applications and other very thin IOT applications.

“We look forward to serving Murata’s customers and are committed to providing the same high quality, low cost products that they enjoy today,” said Anthony Kongats, CAP-XX CEO.

About CAP-XX supercapacitors:

CAP-XX supercapacitors support power requirements including wireless communication (Bluetooth, Bluetooth Smart, Zigbee, Z-Wave, Ant, active RFID), electronic paper and OLED displays, haptic or tactile feedback, vibration alerts, GPS acquisition, and injection or inhalation system delivery. The supercapacitors work with thin-film, solid-state, and other low-power batteries such as coin cells/button cells, energy harvesting modules (solar, vibration/kinetic, RF, and other ambient energy sources), as well as inductive/wireless and cable/cradle fast-charging systems.

About CAP-XX

CAP-XX (LSE:CPX) is a world leader in the design and manufacture of small supercapacitors and energy management systems used in portable and small-scale electronic devices, and large supercapacitor-based modules used in automotive and renewable energy applications. The unique feature of CAP-XX supercapacitors is their very high power density and high-energy storage capacity in space-efficient thin prismatic and compact cylindrical packages. These attributes are essential in many power-hungry applications. For more information about CAP-XX, visit http://www.cap-xx.com or email sales@cap-xx.com.

Share article on social media or email:

ApexNetwork Physical Therapy To Open Its First Texas Clinic in Celina, TX


Kyle Correia, DPT is scheduled to open the first ApexNetwork Physical Therapy clinic in Texas. ApexNetwork Physical Therapy, a leading provider of outpatient physical therapy, is opening the Celina clinic on December 16, 2019. The new clinic is located at 3248 S Preston Road, Suite 110, Celina, TX which is along S Preston Road, a main passage connecting residents with numerous businesses.

ApexNetwork is excited to provide exceptional care throughout Celina and Texas that its brand has become synonymous with. The clinic will staff licensed therapists and offer the full spectrum of rehabilitative treatment and accepting most major insurances.

Dr. Correia received his Doctor of Physical Therapy degree from Texas State University. He also has a Bachelor of Exercise Sports Science from Texas State University. Dr. Correia has a special interest in orthopedics, manual therapy, sports rehabilitation, and other musculoskeletal dysfunctions. Dr. Correia states, “As a proud resident of Celina, TX, I am dedicated to providing a personalized, evidence-based approach to my patients to help them achieve their individualized goals and prevent additional injuries. ApexNetwork Physical Therapy is the perfect fit that matches my beliefs and goals to help treat local residents and build relationships with the members of the community.” In his spare time, Dr. Correia enjoys spending time with his wife and their son, playing golf, and watching sports.

ApexNetwork Physical Therapy offers each patient quality, comprehensive treatment. Our licensed therapists create an individualized treatment plan to suit your specific needs. Our ultimate goal is to provide an unparalleled experience of health and wellness, encouragement, and quality service all in a comfortable and warm environment.

To learn more about ApexNetwork Physical Therapy, or to schedule an appointment, visit ApexNetworkPT.com.

Our philosophy is quite simple – to be the best in rehabilitation. ApexNetwork Physical Therapy accepts all major insurance plans and provides a full spectrum of services including:


We treat a wide range of clinical diagnoses affecting the back, neck, shoulder, elbow, wrist, hand, hip, knee, ankle, and foot. From injuries, sprains, and post-surgical rehabilitation, we focus on pain reduction, helping you reclaim your mobility and strength.


Our customized sports rehabilitation programs focus on functional activities and sport specific training. We also help with injury prevention, management, and education, stretching programs, and sport & team-specific conditioning and training.

  • Industrial Rehabilitation


The Apex Comprehensive Occupational Management and Prevention (ACOMP®) is a full-spectrum industrial strength program that addresses every aspect from prevention to injury resolution. Our facilities have warehouse environments, allowing for unlimited job simulations and work-specific tasks. We also offer Work Hardening, Functional Capacity Evaluations (FCEs), Ergonomics, Injury Causational Analysis, and Job-Site Analysis.


Manual Therapy is exactly what it sounds like: the application of a specific skilled treatment, manually performed by the therapist. This type of therapy helps increase range of motion, induces relaxation, helps control pain, and reduces swelling or mobility restrictions.

  • Vestibular Rehabilitation


Individuals having problems related to dizziness and balance will likely benefit from Balance Therapy. Treatments may involve manual therapy and exercise-based therapy to help improve the vestibular balance system, while other exercises may be needed to improve balance control and reduce the risk of falling.


During the screen, a licensed therapist will meet with you to discuss your condition and provide a brief assessment of your physical and functional abilities. The information collected will help provide insight into the best medical options for you.

If you are a patient, employer, physician, case manager, or insurance company, ApexNetwork Physical Therapy invites you to stop by for a visit. For more information or to schedule an appointment, please reference the following or visit http://www.apexnetworkpt.com.

ABOUT APEXNETWORK PHYSICAL THERAPY

Our mission at ApexNetwork Physical Therapy® is to provide the most sophisticated, individualized treatment and rehabilitation in a comfortable and warm environment. In short, we want to get you back to everyday living as safely and as quickly as possible. How do we do this? It is really quite simple. We are staffed with experienced therapists who have advanced capabilities in orthopedic manual therapy, strength and conditioning, and rehabilitation. This enables us to treat a wide range of clinical diagnoses affecting the back, neck, shoulder, elbow, wrist, hand, hip, knee, ankle, and foot.

We currently have over 80 locations throughout Arizona, Arkansas, Colorado, Florida, Illinois, Kentucky, Maine, Maryland, Missouri, New Mexico, Texas, Virginia, and Wisconsin – and employ over 300 people. ApexNetwork Physical Therapy has earned dozens of awards in its 20 year existence. Most recently we were named among the top 500 franchises in 2019 and Top budget friendly franchises by Entrepreneur Magazine, in addition to America’s Most Honored Business – Top 10% in 2016. We are a BBB Accredited Business and leader in physical therapy. Our services include physical therapy, sports rehab, occupational/hand therapy, industrial rehab, manual therapy, vestibular rehab, and free injury screenings. For more information, visit http://www.apexnetworkpt.com or to find a clinic near you, call 877-224-4354.

ApexNetwork Physical Therapy

3248 S Preston Road, Suite 100 & 110

Celina, TX 75009

214-851-4500

http://www.apexnetworkpt.com

CelinaTX@apexnetworkpt.com

Translational Study Demonstrates Value of MSOT Imaging for the Assessment of Disease Progression in Duchenne Muscular Dystrophy


In this study we were able to visualize collagen in vivo using MSOT imaging. It suggests its application as a non-invasive, age-independent biomarker for Duchenne Muscular Dystrophy.

DMD is the most common lethal inherited muscular disease occurring in about one of 5,000 male births. While affected boys can develop normally, at the age of 4 to 5 years a loss of muscle mass becomes apparent. By the age of 10, characteristic muscle weakness results in the loss of walking ability and finally in respiratory and cardiac failure. Until now, the assessment of disease progression is based on muscle examinations as well as functional testing. However, physical examinations rely on active cooperation and the individual performance on the day and require a minimum age, which limits their clinical utility.

Imaging approaches such as ultrasound and magnetic resonance imaging (MRI) have been investigated as non-invasive and objective disease assessment methods. However, complex scanning protocols limit their application and the need for sedation of very young patients still raises the need for independent easy-to-apply prognostic biomarkers in DMD.

The studies conducted at the University Hospital Erlangen (UHE) included tissues, experimental models, as well as 10 boys and 10 healty volunteers, aged 3 to 10 years. Results demonstrate that MSOT can visualize and quantify the distribution and concentration of collagen as a measure for degenerated muscular tissue, demonstrating a biomarker for DMD disease progression. ‘In this study we were able to visualize collagen in vivo using MSOT imaging’, says Dr. Adrian Regensburger, MD at UHE. ‘It suggests its application as a non-invasive, age-independent biomarker for DMD, thereby potentially filling the urgent clinical need for an easy and objective assessment of DMD disease progression and treatment monitoring’.

Christian Wiest, CEO at iThera Medical comments: ‘We are excited to see that MSOT can potentially aid DMD patients suffering from this severe disease. We will therefore continue to drive research for the use of our imaging technology in DMD and to expand its use into related fields.’

For further information, please contact:

Christian Wiest

Phone: +49 (0)89 700 7449-21

Email: christian.wiest@ithera-medical.com

Share article on social media or email: